Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001883884 | SCV002145784 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2021-12-29 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with MKS1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys220*) in the MKS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MKS1 are known to be pathogenic (PMID: 19466712, 24886560, 26490104). |
Myriad Genetics, |
RCV002307778 | SCV002604004 | likely pathogenic | Bardet-Biedl syndrome 13; Meckel syndrome, type 1; Joubert syndrome 28 | 2021-12-08 | criteria provided, single submitter | clinical testing | NM_017777.3(MKS1):c.658A>T(K220*) is expected to be pathogenic in the context of MKS1-related disorders. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in MKS1, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |